| Phase 1/21 trial |
|
Phase 1/2
|
NCT00507806 |
Mar 2005 → May 2006 |
ischemic stroke |
ImaRx Therapeutics |
Terminated
|
No outcome recorded
|
| Phase 26 trials |
|
Phase 2
|
NCT06571786 |
Dec 2024 → Jul 2025 |
— |
Thomas Jefferson University |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT04021238 |
Oct 2020 → Aug 2022 |
kidney cancer |
UNC Lineberger Comprehensive Cancer Center |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT03907657 |
Sep 2019 → Mar 2023 |
chronic kidney disease, von Hippel-Lindau disease |
UNC Lineberger Comprehensive Cancer Center |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT03196076 |
Aug 2017 → Mar 2021 |
chronic kidney disease, cystic kidney disease |
University of North Carolina, Chapel Hill |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT02967458 |
Feb 2017 → Feb 2018 |
prostate neoplasm |
Thomas Jefferson University |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT02684435 |
Feb 2016 → Jul 2018 |
chronic kidney disease, cystic kidney disease |
University of North Carolina, Chapel Hill |
Completed
|
No outcome recorded
|
| Phase 31 trial |
|
Phase 3
|
NCT06024772 |
Jul → Aug 2026 overdue |
prostate carcinoma |
Thomas Jefferson University |
Not yet recruiting
|
No outcome recorded
|
| Phase 41 trial |
|
Phase 4
|
NCT02880137 |
Sep 2016 → Jun 2018 |
— |
Mayo Clinic |
Completed
|
No outcome recorded
|
| Phase not applicable1 trial |
| — |
NCT01391039 |
Sep 2011 → Jul 2015 |
ductal breast carcinoma in situ |
Sunnybrook Health Sciences Centre |
Terminated
|
No outcome recorded
Stop: Enrollment |
| Comparator or background therapy2 trials |
|
Phase 4
|
NCT04056988 Background |
Jul 2018 → Nov 2023 |
spinal cord injury |
University of Washington |
Completed
|
No outcome recorded
|
| — |
NCT01242020 Background |
Jan → May 2011 |
obesity disorder |
University of Pennsylvania |
Terminated
|
No outcome recorded
|